HOCMIR, that sure is the challenge!
Thanks for sharing these names.
I'll now do some dd on them.
I do hope you're doing some dd on ACTC, With human testing about to start soon and results expected this year, this could (will) be explosive.
ACTC's technology has already shown to work in other countries without side effects. The eye, unlike the entire rest of the body, readily accepts stem cells.
I truly believe this might end up being the stock investment of the century. and disclosure: have a huge position in it and continue to add all the time..
News 
Market Data 
Discover 
AI
